Gene symbol: Drd1

Also known as: D1a; Drd-1; Drd1a

Organism: Rattus norvegicus

Summary: Enables several functions, including G protein-coupled receptor binding activity; G-protein alpha-subunit binding activity; and enzyme binding activity. Involved in several processes, including learning; modulation of chemical synaptic transmission; and response to alkaloid. Located in several cellular components, including caveola; dendrite; and neuronal cell body. Is integral component of membrane. Is active in glutamatergic synapse. Is integral component of postsynaptic membrane and integral component of presynaptic membrane. Used to study Parkinson's disease; end stage renal disease; and obesity. Biomarker of several diseases, including heroin dependence; hyperglycemia; neurodegenerative disease (multiple); tracheal stenosis; and ureteral obstruction. Human ortholog(s) of this gene implicated in hypertension and kidney failure. Orthologous to human DRD1 (dopamine receptor D1). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24316 EnsemblRapid:ENSRNOG00000023688 AllianceGenome:RGD:2518


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0001101 Response to acid chemical
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001508 Action potential
Process GO:0001659 Temperature homeostasis
Process GO:0001661 Conditioned taste aversion
Process GO:0001662 Behavioral fear response
Process GO:0001666 Response to hypoxia
Process GO:0001764 Neuron migration
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001933 Negative regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001963 Synaptic transmission, dopaminergic
Process GO:0001975 Response to amphetamine
Process GO:0002209 Behavioral defense response
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0006468 Protein phosphorylation
Process GO:0006469 Negative regulation of protein kinase activity
Process GO:0006606 Protein import into nucleus
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006886 Intracellular protein transport
Process GO:0006913 Nucleocytoplasmic transport
Process GO:0006936 Muscle contraction
Process GO:0006939 Smooth muscle contraction
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007189 Adenylate cyclase-activating G protein-coupled receptor signaling pathway
Process GO:0007190 Activation of adenylate cyclase activity
Process GO:0007191 Adenylate cyclase-activating dopamine receptor signaling pathway
Process GO:0007200 Phospholipase C-activating G protein-coupled receptor signaling pathway
Process GO:0007204 Positive regulation of cytosolic calcium ion concentration
Process GO:0007210 Serotonin receptor signaling pathway
Process GO:0007212 Dopamine receptor signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007268 Chemical synaptic transmission
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007416 Synapse assembly
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007610 Behavior
Process GO:0007611 Learning or memory
Process GO:0007612 Learning
Process GO:0007613 Memory
Process GO:0007617 Mating behavior
Process GO:0007625 Grooming behavior
Process GO:0007626 Locomotory behavior
Process GO:0007628 Adult walking behavior
Process GO:0007631 Feeding behavior
Process GO:0007632 Visual behavior
Process GO:0008015 Blood circulation
Process GO:0008104 Protein localization
Process GO:0008152 Metabolic process
Process GO:0008306 Associative learning
Process GO:0008344 Adult locomotory behavior
Process GO:0008542 Visual learning
Process GO:0008643 Carbohydrate transport
Process GO:0008645 Hexose transmembrane transport
Process GO:0009314 Response to radiation
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009416 Response to light stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010001 Glial cell differentiation
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010563 Negative regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010941 Regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0014002 Astrocyte development
Process GO:0014070 Response to organic cyclic compound
Process GO:0014072 Response to isoquinoline alkaloid
Process GO:0014075 Response to amine
Process GO:0014821 Phasic smooth muscle contraction
Process GO:0014823 Response to activity
Process GO:0015031 Protein transport
Process GO:0015749 Monosaccharide transmembrane transport
Process GO:0015844 Monoamine transport
Process GO:0015850 Organic hydroxy compound transport
Process GO:0015872 Dopamine transport
Process GO:0016043 Cellular component organization
Process GO:0016310 Phosphorylation
Process GO:0016477 Cell migration
Process GO:0016570 Histone modification
Process GO:0016572 Histone phosphorylation
Process GO:0017157 Regulation of exocytosis
Process GO:0018105 Peptidyl-serine phosphorylation
Process GO:0018193 Peptidyl-amino acid modification
Process GO:0018209 Peptidyl-serine modification
Process GO:0019098 Reproductive behavior
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019226 Transmission of nerve impulse
Process GO:0019228 Neuronal action potential
Process GO:0019229 Regulation of vasoconstriction
Process GO:0019538 Protein metabolic process
Process GO:0019722 Calcium-mediated signaling
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0021537 Telencephalon development
Process GO:0021542 Dentate gyrus development
Process GO:0021543 Pallium development
Process GO:0021544 Subpallium development
Process GO:0021756 Striatum development
Process GO:0021761 Limbic system development
Process GO:0021766 Hippocampus development
Process GO:0021769 Orbitofrontal cortex development
Process GO:0021782 Glial cell development
Process GO:0021826 Substrate-independent telencephalic tangential migration
Process GO:0021830 Interneuron migration from the subpallium to the cortex
Process GO:0021843 Substrate-independent telencephalic tangential interneuron migration
Process GO:0021853 Cerebral cortex GABAergic interneuron migration
Process GO:0021885 Forebrain cell migration
Process GO:0021892 Cerebral cortex GABAergic interneuron differentiation
Process GO:0021894 Cerebral cortex GABAergic interneuron development
Process GO:0021895 Cerebral cortex neuron differentiation
Process GO:0021953 Central nervous system neuron differentiation
Process GO:0021954 Central nervous system neuron development
Process GO:0022008 Neurogenesis
Process GO:0022029 Telencephalon cell migration
Process GO:0022414 Reproductive process
Process GO:0022607 Cellular component assembly
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030154 Cell differentiation
Process GO:0030182 Neuron differentiation
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030336 Negative regulation of cell migration
Process GO:0030432 Peristalsis
Process GO:0030534 Adult behavior
Process GO:0030900 Forebrain development
Process GO:0031279 Regulation of cyclase activity
Process GO:0031281 Positive regulation of cyclase activity
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031667 Response to nutrient levels
Process GO:0032094 Response to food
Process GO:0032355 Response to estradiol
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032526 Response to retinoic acid
Process GO:0032868 Response to insulin
Process GO:0032869 Cellular response to insulin stimulus
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0033036 Macromolecule localization
Process GO:0033238 Regulation of cellular amine metabolic process
Process GO:0033365 Protein localization to organelle
Process GO:0033554 Cellular response to stress
Process GO:0033555 Multicellular organismal response to stress
Process GO:0033673 Negative regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034219 Carbohydrate transmembrane transport
Process GO:0034329 Cell junction assembly
Process GO:0034330 Cell junction organization
Process GO:0034504 Protein localization to nucleus
Process GO:0034762 Regulation of transmembrane transport
Process GO:0034764 Positive regulation of transmembrane transport
Process GO:0034765 Regulation of ion transmembrane transport
Process GO:0034767 Positive regulation of ion transmembrane transport
Process GO:0035094 Response to nicotine
Process GO:0035106 Operant conditioning
Process GO:0035150 Regulation of tube size
Process GO:0035176 Social behavior
Process GO:0035249 Synaptic transmission, glutamatergic
Process GO:0035296 Regulation of tube diameter
Process GO:0035404 Histone-serine phosphorylation
Process GO:0035556 Intracellular signal transduction
Process GO:0035637 Multicellular organismal signaling
Process GO:0036211 Protein modification process
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036294 Cellular response to decreased oxygen levels
Process GO:0040012 Regulation of locomotion
Process GO:0040013 Negative regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042053 Regulation of dopamine metabolic process
Process GO:0042063 Gliogenesis
Process GO:0042069 Regulation of catecholamine metabolic process
Process GO:0042220 Response to cocaine
Process GO:0042221 Response to chemical
Process GO:0042311 Vasodilation
Process GO:0042321 Negative regulation of circadian sleep/wake cycle, sleep
Process GO:0042325 Regulation of phosphorylation
Process GO:0042326 Negative regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042391 Regulation of membrane potential
Process GO:0042592 Homeostatic process
Process GO:0042596 Fear response
Process GO:0042711 Maternal behavior
Process GO:0042749 Regulation of circadian sleep/wake cycle
Process GO:0042752 Regulation of circadian rhythm
Process GO:0042754 Negative regulation of circadian rhythm
Process GO:0042755 Eating behavior
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043200 Response to amino acid
Process GO:0043269 Regulation of ion transport
Process GO:0043270 Positive regulation of ion transport
Process GO:0043278 Response to morphine
Process GO:0043279 Response to alkaloid
Process GO:0043412 Macromolecule modification
Process GO:0043434 Response to peptide hormone
Process GO:0043549 Regulation of kinase activity
Process GO:0043987 Histone H3-S10 phosphorylation
Process GO:0044057 Regulation of system process
Process GO:0044085 Cellular component biogenesis
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0045184 Establishment of protein localization
Process GO:0045187 Regulation of circadian sleep/wake cycle, sleep
Process GO:0045471 Response to ethanol
Process GO:0045761 Regulation of adenylate cyclase activity
Process GO:0045762 Positive regulation of adenylate cyclase activity
Process GO:0045838 Positive regulation of membrane potential
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045936 Negative regulation of phosphate metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0046323 Glucose import
Process GO:0046907 Intracellular transport
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0046958 Nonassociative learning
Process GO:0046959 Habituation
Process GO:0046960 Sensitization
Process GO:0048148 Behavioral response to cocaine
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048468 Cell development
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048520 Positive regulation of behavior
Process GO:0048521 Negative regulation of behavior
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048666 Neuron development
Process GO:0048699 Generation of neurons
Process GO:0048708 Astrocyte differentiation
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050794 Regulation of cellular process
Process GO:0050795 Regulation of behavior
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050805 Negative regulation of synaptic transmission
Process GO:0050806 Positive regulation of synaptic transmission
Process GO:0050808 Synapse organization
Process GO:0050877 Nervous system process
Process GO:0050890 Cognition
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051169 Nuclear transport
Process GO:0051170 Import into nucleus
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051279 Regulation of release of sequestered calcium ion into cytosol
Process GO:0051281 Positive regulation of release of sequestered calcium ion into cytosol
Process GO:0051282 Regulation of sequestering of calcium ion
Process GO:0051338 Regulation of transferase activity
Process GO:0051339 Regulation of lyase activity
Process GO:0051348 Negative regulation of transferase activity
Process GO:0051349 Positive regulation of lyase activity
Process GO:0051482 Positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051703 Biological process involved in intraspecies interaction between organisms
Process GO:0051716 Cellular response to stimulus
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051928 Positive regulation of calcium ion transport
Process GO:0051937 Catecholamine transport
Process GO:0051966 Regulation of synaptic transmission, glutamatergic
Process GO:0051968 Positive regulation of synaptic transmission, glutamatergic
Process GO:0055085 Transmembrane transport
Process GO:0060158 Phospholipase C-activating dopamine receptor signaling pathway
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060259 Regulation of feeding behavior
Process GO:0060291 Long-term synaptic potentiation
Process GO:0060292 Long-term synaptic depression
Process GO:0060322 Head development
Process GO:0060548 Negative regulation of cell death
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0060746 Parental behavior
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070482 Response to oxygen levels
Process GO:0070727 Cellular macromolecule localization
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071453 Cellular response to oxygen levels
Process GO:0071456 Cellular response to hypoxia
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071702 Organic substance transport
Process GO:0071704 Organic substance metabolic process
Process GO:0071705 Nitrogen compound transport
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0071867 Response to monoamine
Process GO:0071868 Cellular response to monoamine stimulus
Process GO:0071869 Response to catecholamine
Process GO:0071870 Cellular response to catecholamine stimulus
Process GO:0072594 Establishment of protein localization to organelle
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090659 Walking behavior
Process GO:0097154 GABAergic neuron differentiation
Process GO:0097305 Response to alcohol
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0098664 G protein-coupled serotonin receptor signaling pathway
Process GO:0098916 Anterograde trans-synaptic signaling
Process GO:0099010 Modification of postsynaptic structure
Process GO:0099170 Postsynaptic modulation of chemical synaptic transmission
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0099536 Synaptic signaling
Process GO:0099537 Trans-synaptic signaling
Process GO:0099563 Modification of synaptic structure
Process GO:0099565 Chemical synaptic transmission, postsynaptic
Process GO:1900271 Regulation of long-term synaptic potentiation
Process GO:1900273 Positive regulation of long-term synaptic potentiation
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1903169 Regulation of calcium ion transmembrane transport
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903350 Response to dopamine
Process GO:1903351 Cellular response to dopamine
Process GO:1903522 Regulation of blood circulation
Process GO:1903530 Regulation of secretion by cell
Process GO:1904062 Regulation of cation transmembrane transport
Process GO:1904064 Positive regulation of cation transmembrane transport
Process GO:1904427 Positive regulation of calcium ion transmembrane transport
Process GO:1904659 Glucose transmembrane transport
Process GO:1904936 Interneuron migration
Process GO:1905114 Cell surface receptor signaling pathway involved in cell-cell signaling
Process GO:2000145 Regulation of cell motility
Process GO:2000146 Negative regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000253 Positive regulation of feeding behavior
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Process GO:2001222 Regulation of neuron migration
Process GO:2001224 Positive regulation of neuron migration
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005783 Endoplasmic reticulum
Component GO:0005789 Endoplasmic reticulum membrane
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0005901 Caveola
Component GO:0005929 Cilium
Component GO:0009986 Cell surface
Component GO:0012505 Endomembrane system
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0031090 Organelle membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0031253 Cell projection membrane
Component GO:0031984 Organelle subcompartment
Component GO:0036477 Somatodendritic compartment
Component GO:0042175 Nuclear outer membrane-endoplasmic reticulum membrane network
Component GO:0042734 Presynaptic membrane
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043197 Dendritic spine
Component GO:0043198 Dendritic shaft
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043679 Axon terminus
Component GO:0044297 Cell body
Component GO:0044306 Neuron projection terminus
Component GO:0044309 Neuron spine
Component GO:0044326 Dendritic spine neck
Component GO:0044327 Dendritic spine head
Component GO:0044853 Plasma membrane raft
Component GO:0045121 Membrane raft
Component GO:0045202 Synapse
Component GO:0045211 Postsynaptic membrane
Component GO:0060170 Ciliary membrane
Component GO:0070161 Anchoring junction
Component GO:0071944 Cell periphery
Component GO:0097060 Synaptic membrane
Component GO:0097447 Dendritic tree
Component GO:0097730 Non-motile cilium
Component GO:0098588 Bounding membrane of organelle
Component GO:0098590 Plasma membrane region
Component GO:0098793 Presynapse
Component GO:0098794 Postsynapse
Component GO:0098827 Endoplasmic reticulum subcompartment
Component GO:0098857 Membrane microdomain
Component GO:0098889 Intrinsic component of presynaptic membrane
Component GO:0098936 Intrinsic component of postsynaptic membrane
Component GO:0098978 Glutamatergic synapse
Component GO:0098982 GABA-ergic synapse
Component GO:0099055 Integral component of postsynaptic membrane
Component GO:0099056 Integral component of presynaptic membrane
Component GO:0099240 Intrinsic component of synaptic membrane
Component GO:0099699 Integral component of synaptic membrane
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Function GO:0001588 Dopamine neurotransmitter receptor activity, coupled via Gs
Function GO:0001664 G protein-coupled receptor binding
Function GO:0001965 G-protein alpha-subunit binding
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0004930 G protein-coupled receptor activity
Function GO:0004952 Dopamine neurotransmitter receptor activity
Function GO:0004993 G protein-coupled serotonin receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008227 G protein-coupled amine receptor activity
Function GO:0019899 Enzyme binding
Function GO:0019902 Phosphatase binding
Function GO:0019903 Protein phosphatase binding
Function GO:0030594 Neurotransmitter receptor activity
Function GO:0031701 Angiotensin receptor binding
Function GO:0031750 D3 dopamine receptor binding
Function GO:0035240 Dopamine binding
Function GO:0038023 Signaling receptor activity
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0044877 Protein-containing complex binding
Function GO:0050780 Dopamine receptor binding
Function GO:0051117 ATPase binding
Function GO:0060089 Molecular transducer activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0098960 Postsynaptic neurotransmitter receptor activity
Function GO:0099589 Serotonin receptor activity
Function GO:1901338 Catecholamine binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
WikiPathways WP1281 Hypothetical network for drug addiction
WikiPathways WP276 Monoamine GPCRs
WikiPathways WP473 GPCRs, class A rhodopsin-like

Expression profile of Drd1 in omics data



ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.083998291
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.041032828
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 2.947081661
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.015243274
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.215901394
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.004846619

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 4.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.937809
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.308507
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.103632
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.044964
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.901962
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.025231

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.447
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.765
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.779
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 0.999
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 1.328

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.570882108
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 9.0955867315
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.928750630500002

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 29.133333333333336
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 17.666666666666668
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 23.233333333333334
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 15.700000000000001
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 13.266666666666666
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 47.300000000000004
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 45.9
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 39.73333333333333
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 27.03333333333333
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 71.06666666666668
GSM27494 CTL_a (control, 1st replicate) 26.53333333333333
GSM27495 CTL_b (control, 2nd replicate) 41.26666666666667
GSM27496 CTL_c (control, 3rd replicate) 30.0
GSM27497 CTL_d (control, 4th replicate) 17.866666666666667
GSM27498 CTL_e (control, 5th replicate) 29.666666666666668
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 28.03333333333333
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 11.933333333333332
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 25.266666666666666
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 17.5
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 48.46666666666667
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 94.36666666666667
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 36.333333333333336
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 37.833333333333336
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 62.666666666666664
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 91.7
GSM27509 ISCH_a (ischemia, 1st replicate) 38.0
GSM27510 ISCH_b (ischemia, 2nd replicate) 49.06666666666666
GSM27511 ISCH_c (ischemia, 3rd replicate) 8.1
GSM27512 ISCH_d (ischemia, 4th replicate) 21.8
GSM27513 ISCH_e (ischemia, 5th replicate) 15.666666666666666

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 336.5
GSM30791 baseline control 02 male, 275-300g 419.35
GSM30792 baseline control 03 male, 275-300g 525.15
GSM30793 baseline control 04 male, 275-300g 258.4
GSM30794 baseline control 05 male, 275-300g 307.25
GSM30795 baseline control 06 male, 275-300g 309.7
GSM30796 baseline control 07 male, 275-300g 213.55
GSM30797 baseline control 08 male, 275-300g 302.05
GSM30798 baseline control 09 male, 275-300g 235.8
GSM30799 pain 01 292.9
GSM30800 pain 02 345.45
GSM30801 pain 03 279.2
GSM30802 pain 04 220.64999999999998
GSM30803 pain 05 361.45000000000005
GSM30804 FC 01 270.45
GSM30805 FC 02 199.85000000000002
GSM30806 FC 03 241.45
GSM30807 FC 04 283.6
GSM30808 FC 05 235.89999999999998
GSM30809 IFC 01 341.45000000000005
GSM30810 IFC 02 282.75
GSM30811 IFC 03 369.65000000000003
GSM30812 IFC 04 319.8
GSM30813 IFC 05 319.4
GSM99800 isoflurane 01 male, 275-300g 338.0
GSM99801 isoflurane 02 male, 275-300g 277.35
GSM99802 isoflurane 03 male, 275-300g 312.15
GSM99803 isoflurane 04 male, 275-300g 255.0
GSM99804 isoflurane 05 male, 275-300g 417.95

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 4.79845
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 3.75945
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 4.5087
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 4.360250000000001
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 4.74465
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 4.6164
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 3.6906499999999998
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 4.21515
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 4.3373

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 7.97188
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 6.87057
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 3.91277
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 3.82594
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 3.77536
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 3.80815
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 4.29676
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 3.43839
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 8.15976
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 7.91208
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 3.57798
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 3.48274
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.84245
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 4.50405
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 3.71395
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.01091

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.199285
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.232042
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.294578
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.300136
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.340244
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.161496
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.281327
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.352623
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.278385
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.172652
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.171964
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.244073
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.364901
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.178394
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.279812
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.379016
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.252201
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.306543
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.267083
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.28248
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.262056
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.217646
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.283477
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.433483
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.28058
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.262372
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.310188
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.20061
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.258243
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.234211
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.171048
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.359442
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.191734
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.16721
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.335285
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.260884
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.117367
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.298514
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.226779
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.340672
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.439701
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.329319
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.23229
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.324513
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.400069

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 294.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 174.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 210.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 276.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 233.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 154.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 237.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 211.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 173.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 373.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 297.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 234.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 181.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 322.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 305.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 196.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 291.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 257.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 208.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 159.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 279.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 339.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 317.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 245.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 268.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 103.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 196.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 215.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 346.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 275.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 190.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 300.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 235.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 192.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 272.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 181.0

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 11.333333333333334
GSM5121 Isoflurane single exposure control-2 19.133333333333333
GSM5122 Isoflurane single exposure control-3 84.3
GSM5124 Isoflurane single exposure 1 hr-1 36.6
GSM5126 Isoflurane single exposure 1 hr-2 16.933333333333334
GSM5127 Isoflurane single exposure 2 hr-1 18.099999999999998
GSM5130 Isoflurane single exposure 2 hr-2 46.800000000000004
GSM5131 Isoflurane single exposure 2 hr-3 18.8

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.7176444044999997
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.7892252715000003
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.5660159475000004
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.6519421765
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.6403372155
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.8470739844999997
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6980907700000003
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6486120805
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.5127652234999998
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.638743369
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.6284807700000004
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5845608285
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.4170512365
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.7281917289999997
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.6961407284999996
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.6549933770000003
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.0323282305
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.73633364
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.814420921
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.8409158559999996
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.7110810909999996
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.6089554855
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.63995398
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.746855118

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.838288
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.929706
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.076349
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.843046
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.73282
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.84912
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.781669
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.871806
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.943061
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.792864
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.590704
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.996055
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.802926
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.926816
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.817195
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.915023
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.898044
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.949037
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.850422
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.990559
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.811174
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.961106
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.820669
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.794703

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 6.414813286999999
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 11.790105933
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 13.288483763
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 25.42601346
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 17.664059685999998
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 3.7297238125
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 8.3539067915
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 36.5976883
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 31.216599683499997
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 28.4993521545
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 9.3652324435
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 9.069755035
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 11.705127805
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 16.1665380615

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.7176444044999997
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.7892252715000003
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.5660159475000004
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.6519421765
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.6403372155
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.8470739844999997
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6980907700000003
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6486120805
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.5127652234999998
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.638743369
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.6284807700000004
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5845608285
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.4170512365
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.7281917289999997
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.6961407284999996
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.6549933770000003
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.0323282305
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.73633364
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.814420921
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.8409158559999996
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.7110810909999996
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.6089554855
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.63995398
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.746855118
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 6.414813286999999
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 11.790105933
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 13.288483763
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 25.42601346
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 17.664059685999998
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 3.7297238125
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 8.3539067915
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 36.5976883
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 31.216599683499997
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 28.4993521545
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 9.3652324435
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 9.069755035
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 11.705127805
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 16.1665380615

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 61.03333333333333
GSM5084 Control 2 45.333333333333336
GSM5085 Control 3 46.03333333333333
GSM5086 Control 4 50.96666666666666
GSM5087 Control 5 55.833333333333336
GSM5090 Control 6 52.20000000000001
GSM5105 Control 7 64.46666666666665
GSM5106 Control 8 59.96666666666666
GSM5107 Control 9 58.5
GSM5108 Halothane 10 exposure-1 57.06666666666666
GSM5109 Halothane 10 exposures-2 64.46666666666665
GSM5110 Halothane 10 exposures-3 23.833333333333332
GSM5111 Halothane 5 exposures-1 46.43333333333334
GSM5112 Halothane 5 exposures-2 63.5
GSM5113 Halothane 5 exposures-3 19.400000000000002
GSM5114 Isoflurane 10 exposures-1 52.199999999999996
GSM5115 Isoflurane 10 exposures-2 63.53333333333333
GSM5116 Isoflurane 10 exposures-3 29.266666666666666
GSM5117 Isoflurane 5 exposures-1 41.833333333333336
GSM5118 Isoflurane 5 exposures-2 61.4
GSM5119 Isoflurane 5 exposures-3 18.833333333333332
GSM11379 Control 10 56.133333333333326
GSM11380 Control 11 47.166666666666664
GSM11381 Control 12 45.13333333333333

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 1.15798
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 4.6305499999999995